A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
Recruiting · NCT07851220 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-10-01 | NCT07851220 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Academic Medical Research Institute | Los Angeles | United States | 10 |
| Bioresearch Partner- Martin Luther King Jr. | Miami | United States | 1 |
| Bioresearch Partner- Pembroke Pines | Pembroke Pines | United States | 1 |
| Bioresearch Partner-Jackson West | Doral | United States | 1 |